Wall Street's Bull Case for Bristol Myers Squibb Is Getting Louder
Key PointsBristol Myers Squibb's stock is up more than 17% so far this year.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.